Elizabeth Ortíz-Sánchez

1.7k citations
41 papers · 1.2k indexed · h-index 19

Elizabeth Ortíz-Sánchez

37 papers receiving 1.2k citations

Peers

Elizabeth Ortíz-Sánchez
Comparison fields: 5 of 120
  • Molecular Biology 596
  • Oncology 471
  • Cancer Research 253
  • Immunology 173
  • Pulmonary and Respiratory Medicine 133
Replace Jihong Feng with:
Jihong Feng China
Yue Meng China
Yuqin Yao China
Flaubert Mbeunkui United States
Arash Soltani Iran
Rajakishore Mishra India
So‐Yeon Park South Korea
Ronghua Zhang China
Hongwei He China
Elizabeth Ortíz-Sánchez relative to Jihong Feng China Jihong Feng's profile →
Citations per field
00.5×1.5×
Jihong Feng · 1×
Citations per year

Countries citing papers authored by Elizabeth Ortíz-Sánchez

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Ortíz-Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Ortíz-Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Ortíz-Sánchez more than expected).

Fields of papers citing papers by Elizabeth Ortíz-Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Ortíz-Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Ortíz-Sánchez. The network helps show where Elizabeth Ortíz-Sánchez may publish in the future.

Co-authorship network of co-authors of Elizabeth Ortíz-Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Ortíz-Sánchez. A scholar is included among the top collaborators of Elizabeth Ortíz-Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Ortíz-Sánchez. Elizabeth Ortíz-Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 3
3 3
4 0
5 0
6 6
7 8
8 45
9 115
10 11
11 222
12 12
13 35
14 35
15 49
16 55
17 35
18 34
19 2
20 9

About Elizabeth Ortíz-Sánchez

Elizabeth Ortíz-Sánchez is a scholar working on Oncology, Cancer Research and Immunology, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (12 papers), Cancer-related Molecular Pathways (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Oncology (471 citations), Cancer Research (253 citations) and Molecular Biology (596 citations). Elizabeth Ortíz-Sánchez has collaborated with scholars based in Mexico, United States and Argentina. Frequent co-authors include Alejandro Garcı́a-Carrancá, Miguel Ángel Ibáñez-Hernández, Luis A. Herrera, Bernardo Cacho‐Díaz, Gervith Reyes-Soto, Talía Wegman-Ostrosky, Gustavo Helguera, Tracy R. Daniels‐Wells, Manuel L. Penichet and Karen Griselda de la Cruz-López. Their work appears in journals such as International Journal of Molecular Sciences, Gene and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026